Envoy Medical Statistics
Total Valuation
Envoy Medical has a market cap or net worth of $54.86 million. The enterprise value is $30.50 million.
Important Dates
The last earnings date was Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Envoy Medical has 76.88 million shares outstanding. The number of shares has increased by 80.58% in one year.
| Current Share Class | 76.88M |
| Shares Outstanding | 76.88M |
| Shares Change (YoY) | +80.58% |
| Shares Change (QoQ) | +142.13% |
| Owned by Insiders (%) | 37.17% |
| Owned by Institutions (%) | 12.40% |
| Float | 38.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 234.45 |
| Forward PS | 298.81 |
| PB Ratio | 5.20 |
| P/TBV Ratio | 5.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 130.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.27 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -71.29% |
| Return on Invested Capital (ROIC) | -254.89% |
| Return on Capital Employed (ROCE) | -130.21% |
| Weighted Average Cost of Capital (WACC) | 16.04% |
| Revenue Per Employee | $4,979 |
| Profits Per Employee | -$600,830 |
| Employee Count | 47 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.52% in the last 52 weeks. The beta is 1.90, so Envoy Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.90 |
| 52-Week Price Change | -57.52% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.84 |
| Relative Strength Index (RSI) | 56.32 |
| Average Volume (20 Days) | 125,490 |
Short Selling Information
The latest short interest is 1.36 million, so 1.77% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 1.77% |
| Short % of Float | 3.56% |
| Short Ratio (days to cover) | 8.80 |
Income Statement
In the last 12 months, Envoy Medical had revenue of $234,000 and -$28.24 million in losses. Loss per share was -$0.80.
| Revenue | 234,000 |
| Gross Profit | -537,000 |
| Operating Income | -22.93M |
| Pretax Income | -23.11M |
| Net Income | -28.24M |
| EBITDA | -22.62M |
| EBIT | -22.93M |
| Loss Per Share | -$0.80 |
Full Income StatementBalance Sheet
The company has $25.25 million in cash and $889,000 in debt, with a net cash position of $24.36 million or $0.32 per share.
| Cash & Cash Equivalents | 25.25M |
| Total Debt | 889,000 |
| Net Cash | 24.36M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 10.55M |
| Book Value Per Share | 0.14 |
| Working Capital | 15.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.54 million and capital expenditures -$173,000, giving a free cash flow of -$20.71 million.
| Operating Cash Flow | -20.54M |
| Capital Expenditures | -173,000 |
| Depreciation & Amortization | 314,000 |
| Net Borrowing | 4.10M |
| Free Cash Flow | -20.71M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
| Gross Margin | -229.49% |
| Operating Margin | -9,800.00% |
| Pretax Margin | -9,875.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Envoy Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.58% |
| Shareholder Yield | -80.58% |
| Earnings Yield | -51.47% |
| FCF Yield | -37.75% |
Analyst Forecast
The average price target for Envoy Medical is $2.50, which is 250.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 250.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Envoy Medical has an Altman Z-Score of -15.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.95 |
| Piotroski F-Score | 3 |
